{"text": ["AbbVie", "Showcases", "the", "Depth", "of", "its", "Rheumatology", "Portfolio", "with", "New", "Data", "Presented", "at", "the", "EULAR", "2021", "Virtual", "Congress", "of", "Rheumatology"], "created_at": "2021-05-25 12:00:00"}
{"text": ["AbbVie", "Receives", "European", "Commission", "Approval", "of", "VENCLYXTO\u00ae", "(venetoclax)", "in", "Combination", "with", "a", "Hypomethylating", "Agent", "for", "Patients", "with", "Newly", "Diagnosed", "Acute", "Myeloid", "Leukemia", "Who", "Are", "Ineligible", "for", "Intensive", "Chemotherapy"], "created_at": "2021-05-25 12:00:00"}
{"text": ["2", "High-Yield", "Dividend", "Stocks", "for", "2021"], "created_at": "2021-05-25 11:12:00"}
{"text": ["3", "Strong", "Stocks", "for", "Your", "Income", "Tax", "Return"], "created_at": "2021-05-25 10:08:00"}
